Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Hopstem Logo
Hopstem Growth Score
64
CB Rank
57745
Heat Score
61
Hopstem is a pharmaceutical company engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.
Founded
obfuscation
PrivateSeries B Hangzhou, Zhejiang, China51-100 www.hopstem.com/
Biotechnology
Health Care
Overview

Hopstem
Total Funding
obfuscation
Growth Score
64
Heat Score
61

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score64
-1 pts
in past quarter
Heat Score 61
1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Hopstem

CB Rank
57745
Hopstem is a pharmaceutical company engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.
Founded
obfuscation
PrivateSeries B Hangzhou, Zhejiang, China51-100 www.hopstem.com/
Biotechnology
Health Care

Funding Rounds

Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Key People

Details

Legal Name Zhejiang Huode Biological Engineering Co., Ltd.
Also Known As 浙江霍德生物工程有限公司, Hopstem Biotech
Operating Status Active
Company Type For Profit
Founders  Jing Fan
About the Company
Hopstem is a Hangzhou-based pharmaceutical company, engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.
Phone Number 0571-88197776
Contact Email info@hopstem.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

hNPC01 Injection
An iPSC-derived human forebrain neural progenitor cell injection for treating ischemic stroke sequelae and other CNS disorders.
hNPC02 Spinal Cord Neural Progenitor Cells
iPSC-derived spinal cord neural progenitor cells under development for spinal cord injury and ALS treatment.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Hopstem Logo
Series B - Hopstem
3
obfuscation
— Series B
obfuscation
Series B - Hopstem Logo
Series B - Hopstem
3
obfuscation
— Series B
obfuscation
Series B - Hopstem Logo
Series B - Hopstem
3
obfuscation
— Series B
obfuscation
Series B - Hopstem Logo
Series B - Hopstem
3
obfuscation
— Series B
obfuscation
Series B - Hopstem Logo
Series B - Hopstem
3
obfuscation
— Series B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Hopstem Logo
Series B - Hopstem
3
obfuscation
— Series B
obfuscation
Series B - Hopstem Logo
Series B - Hopstem
3
obfuscation
— Series B
obfuscation
Series B - Hopstem Logo
Series B - Hopstem
3
obfuscation
— Series B
obfuscation
Series B - Hopstem Logo
Series B - Hopstem
3
obfuscation
— Series B
obfuscation
Series B - Hopstem Logo
Series B - Hopstem
3
obfuscation
— Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Lilly Asia Ventures Logo
Lilly Asia Ventures
—
Series B - Hopstem Logo
Series B - Hopstem
—
Lilly Asia Ventures Logo
Lilly Asia Ventures
—
Series B - Hopstem Logo
Series B - Hopstem
—
Lilly Asia Ventures Logo
Lilly Asia Ventures
—
Series B - Hopstem Logo
Series B - Hopstem
—
Lilly Asia Ventures Logo
Lilly Asia Ventures
—
Series B - Hopstem Logo
Series B - Hopstem
—
Lilly Asia Ventures Logo
Lilly Asia Ventures
—
Series B - Hopstem Logo
Series B - Hopstem
—
Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 1 Contacts 2

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

488

IT Spend

$987KThis year, Hopstem is projected to spend $987K on IT, according to Aberdeen.

Active Website Tech Count

3Hopstem is actively using 3 technologies for its website, according to BuiltWith. These include Euro and  CommonCrawl Top 10m.
Sub-Organizations
Frequently Asked Questions

Where is Hopstem's headquarters? Hopstem is located in Hangzhou, Zhejiang, China.Who invested in Hopstem? Hopstem has 7 investors including Lilly Asia Ventures and  Hillhouse Ventures.When was the last funding round for Hopstem? Hopstem closed its last funding round on
obfuscation
from a Series B round.Who are Hopstem's competitors? Alternatives and possible competitors to Hopstem may include Aspen Neuroscience, Lineage Cell Therapeutics, and  BrainStorm Cell Therapeutics.How much funding has Hopstem raised to date? Hopstem has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|